The global enteral feeding devices market size was USD 4.50 billion in 2023, estimated at USD 4.73 billion in 2024 and is anticipated to reach around USD 7.67 billion by 2034, expanding at a CAGR of 4.95% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
5.1. Covid-19: Enteral Feeding Devices Industry Impact
5.2. Enteral Feeding Devices Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Enteral Feeding Devices Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Enteral Feeding Devices Market Players to deal with Covid-19 Pandemic Scenario
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Integration of safety and programming features within the feeding devices
6.1.1.2. Development of portable feeding devices
6.1.2. Market Restraints
6.1.2.1. Complications associated with enteral feeding devices
6.1.3. Market Opportunities
6.1.3.1. Rapidly increasing awareness regarding enteral feeding
6.1.3.2. Increased focus on the improvement of healthcare infrastructure
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Enteral Feeding Devices Market Revenue by Market Players
7.1.1.2. Enteral Feeding Devices Market Revenue Market Share by Market Players
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users
8.1. Enteral Feeding Devices Market, by Product Type, 2024-2034
8.1.1. Administration Sets
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Enteral Feeding Pump
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Enteral Syringe
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Enteral Feeding Tube
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2021-2034)
9.1. Enteral Feeding Devices Market, by Application, 2024-2034
9.1.1. Gastrointestinal Disease
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Cancer
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Malnutrition
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Neurological Disorder
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2021-2034)
10.1. Enteral Feeding Devices Market, by Age Group, 2021-2034
10.1.1. Pediatrics
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Adult
10.1.2.1. Market Revenue and Forecast (2021-2034)
11.1. Enteral Feeding Devices Market, by End User, 2024-2034
11.1.1. Gastrointestinal Disease
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Cancer
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Malnutrition
11.1.3.1. Market Revenue and Forecast (2021-2034)
11.1.4. Neurological Disorder
11.1.4.1. Market Revenue and Forecast (2021-2034)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2021-2034)
12.1. North America
12.1.1. Market Revenue Forecast by Product Type(2021-2034)
12.1.2. Market Revenue Forecast by Application (2021-2034)
12.1.3. Market Revenue Forecast by Age Group (2021-2034)
12.1.4. Market Revenue Forecast by End User (2021-2034)
12.1.5. U.S
12.1.5.1. Market Revenue Forecast (2021-2034)
12.1.6. Canada
12.1.6.1. Market Revenue Forecast (2021-2034)
12.2. Europe
12.2.1. Market Revenue Forecast by Product Type (2021-2034)
12.2.2. Market Revenue Forecast by Application (2021-2034)
12.2.3. Market Revenue Forecast by Age Group (2021-2034)
12.2.4. Market Revenue Forecast by End User (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue Forecast (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue Forecast (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue Forecast (2021-2034)
12.2.8. Rest of EU
12.2.8.1. Market Revenue Forecast (2021-2034)
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue Forecast by Product Type (2021-2034)
12.3.2. Market Revenue Forecast by Application (2021-2034)
12.3.3. Market Revenue Forecast by Age Group (2021-2034)
12.3.4. Market Revenue Forecast by End User (2021-2034)
12.3.5. China
12.3.5.1. Market Revenue Forecast (2021-2034)
12.3.6. India
12.3.6.1. Market Revenue Forecast (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue Forecast (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue Forecast (2021-2034)
12.4. LATAM
12.4.1. Market Revenue Forecast by Product Type (2021-2034)
12.4.2. Market Revenue Forecast by Application (2021-2034)
12.4.3. Market Revenue Forecast by Age Group (2021-2034)
12.4.4. Market Revenue Forecast by End User (2021-2034)
12.4.5. Brazil
12.4.5.1. Market Revenue Forecast (2021-2034)
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue Forecast (2021-2034)
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue Forecast by Product Type (2021-2034)
12.5.2. Market Revenue Forecast by Application (2021-2034)
12.5.3. Market Revenue Forecast by Age Group (2021-2034)
12.5.4. Market Revenue Forecast by End User (2021-2034)
12.5.5. GCC
12.5.5.1. Market Revenue Forecast (2021-2034)
12.5.6. North Africa
12.5.6.1. Market Revenue Forecast (2021-2034)
12.5.7. South Africa
12.5.7.1. Market Revenue Forecast (2021-2034)
12.5.8. Rest of MEA
12.5.8.1. Market Revenue Forecast (2021-2034)
13.1. Cook Medical
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. Product Portfolio Analysis
13.1.2.1. Product Details, Specification, Application
13.1.3. Revenue, Price, and Gross Margin
13.1.4. Recent Developments and Strategies
13.2. Abott Laboratories
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin
13.2.4. Recent Developments and Strategies
13.3. Fresenius Kabi
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin
13.3.4. Recent Developments and Strategies
13.4. Halyard Health
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin
13.4.4. Recent Developments and Strategies
13.5. Medtronic
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin
13.5.4. Recent Developments and Strategies
13.6. Moog, Inc
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin
13.6.4. Recent Developments and Strategies
13.7. Nestle Health Science
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin
13.7.4. Recent Developments and Strategies
13.8. VYGON
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin
13.8.4. Recent Developments and Strategies
13.9. Danone
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin
13.9.4. Recent Developments and Strategies
13.10. Cardinal Health
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin
13.10.4. Recent Developments and Strategies
13.11. B.Braun
13.11.1. Company Overview, Business Information, Regional Presence
13.11.2. Product Portfolio Analysis
13.11.2.1. Product Details, Specification, Application
13.11.3. Revenue, Price, and Gross Margin
13.11.4. Recent Developments and Strategies
13.12. Boston Scientific
13.12.1. Company Overview, Business Information, Regional Presence
13.12.2. Product Portfolio Analysis
13.12.2.1. Product Details, Specification, Application
13.12.3. Revenue, Price, and Gross Margin
13.12.4. Recent Developments and Strategies
13.13. C.R. Bard
13.13.1. Company Overview, Business Information, Regional Presence
13.13.2. Product Portfolio Analysis
13.13.2.1. Product Details, Specification, Application
13.13.3. Revenue, Price, and Gross Margin
13.13.4. Recent Developments and Strategies
13.14. Conmed Corporation
13.14.1. Company Overview, Business Information, Regional Presence
13.14.2. Product Portfolio Analysis
13.14.2.1. Product Details, Specification, Application
13.14.3. Revenue, Price, and Gross Margin
13.14.4. Recent Developments and Strategies
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample